Track-And-Trace: With Deadline a Year Away, Some Lessons from Early Adopters
This article was originally published in The Gold Sheet
Executive Summary
EMD Serono has been tracking Serostim packages since 2002; J&J is using Prezista 600 mg as a trial run for serialization.
You may also be interested in...
J&J Building Electronic Drug-Tracking System In Anticipation of California’s E-Pedigree
House discussion draft of track-and-trace legislation draws fire from Democrats during April 25 hearings for failing to require a unit-level tracking system, but Energy and Commerce Committee Chairman plans markup of a bill in May and predicts a final measure will reach President Obama’s desk by the August recess.
Full Track-and-Trace Anti-Counterfeiting Not Feasible, Industry Tells FDA
The U.S. pharmaceutical industry is telling FDA that a full track-and-trace approach for following drugs through the supply chain is not the best way of dealing with the growing counterfeit problem. In the meantime, industry is devising a number of different approaches.
California E-Pedigree Law Pushes Final Implementation Back To 2016
California's latest electronic pedigree law pushes the deadline for all drugs sold in the state to carry track-and-trace information to 2016, a year later than an earlier version that was under consideration